Blog

Amazon's AMZN unprecedented datacenter expansion is emerging as the company's most powerful growth catalyst, with AWS infrastructure investments reaching historic levels that position the stock for

Investors in Universal Display Corporation OLED need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $60 Call had some of the

Vertiv VRT and Super Micro Computer SMCI are major players in the data center market, particularly in the rapidly growing area of AI data center infrastructure and liquid cooling solutions. While

Investors in Mativ Holdings, Inc. MATV need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $15 Put had some of the highest implied

Cenovus Energy Inc. CVE, a Canadian integrated energy firm, has provided an update about its 2026 capital spending guidance and the expected upstream and downstream production in the upcoming year

Pre-market futures are averaging out to be flat at this hour, although we’re seeing a wider band of trading. The blue-chip Dow and the small-cap Russell 2000 — up +110 points and +2 points

Shares of Kewaunee Scientific Corporation KEQU have declined 1.3% since reporting results for the second quarter of fiscal 2026. This compares with the S&P 500 index’s 0.7% return over the same time

AppLovin Corporation APP has surged 89% over the past six months, outpacing the broader industry’s modest 20% rally.

                                                       Image Source: Zacks

Shares of Oil-Dri Corporation of America ODC have underperformed the broader market following the release of its first-quarter fiscal 2026 results. Shares of Oil-Dri have declined 6.7% since

Ball Corporation BALL announced that it inked a definitive agreement to buy an 80% stake in Benepack's European beverage can manufacturing businesses. The move optimizes Ball Corp’s European

Stitch Fix, Inc. SFIX entered fiscal 2026 with accelerating Average Order Value (AOV) growth, reinforcing the strength of its transformation strategy. In the fiscal first quarter, AOV increased 9.6%

lululemon athletica inc. LULU reported third-quarter fiscal 2025 results, wherein revenues and earnings per share (EPS) beat the Zacks Consensus Estimate. The company’s top line improved year over

Interactive Brokers Group, Inc.’s IBKR greatest strength in the brokerage space stems from its deep, multi-asset global market access, which remains unmatched by most retail and even many

Shares of SoFi Technologies, Inc. SOFI have surged 82% in the past six months against the industry’s 1% decline.

                                                    Image Source: Zacks Investment

Disney's DIS landmark $1 billion investment in OpenAI positions the entertainment giant at the forefront of generative AI adoption, yet persistent headwinds in linear television and streaming

Broadcom AVGO reported fourth-quarter fiscal 2025 non-GAAP earnings of $1.95 per share, beating the Zacks Consensus Estimate by 4.3% and jumping 37.3% year over year.Revenues rallied 28.2% year over

SkyWest, Inc. (SKYW) has been benefiting from flying contract rate increases, fleet modernization techniques and consistent shareholder-friendly initiatives. The positive sentiment surrounding SKYW

Digital Turbine APPS and PubMatic PUBM are both part of the digital advertisement market, serving two different verticals. Digital Turbine is deeply integrated as an on-device advertising and

Old Dominion Freight Line, Inc. (ODFL) looks highly unattractive from a valuation standpoint. Considering the forward 12-month price-to-sales ratio (P/S-F12M), ODFL has a forward 12-month P/S-F12M

Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply constraints for its semaglutide-based GLP-1 blockbusters — Ozempic for type

Friday, December 12, 2025Pre-market futures are averaging out to be flat at this hour, although we’re seeing a wider band of trading. The blue-chip Dow and the small-cap Russell 2000 — up +110

Bristol Myers BMY has a broad oncology portfolio, which includes blockbuster immuno-oncology drugs, Opdivo, Opdivo Qvantig and Yervoy, among others.

Among these, Opdivo (nivolumab) is the top

Electric Vehicle (EV) giant Tesla TSLA has introduced an all-out discount strategy to boost fourth-quarter sales numbers for Model Y. As the company is in the final leg of the year, it is offering a

Synopsys SNPS reported non-GAAP earnings of $2.90 per share for the fourth quarter of fiscal 2025, which beat the Zacks Consensus Estimate by 3.94%. The bottom line decreased 14.7% on a